Table 3.
Studies Investigating Mesenchymal Stem Cell-derived Extracellular Vesicles in Liver Disease
Model of liver disease | Source of MSC EVs | Bioactive cargo | References |
---|---|---|---|
| |||
TNF-α/Act-D in mice | Mouse bone marrow | Y-RNA-1 | (62) |
D-Gal-N/LPS in mice | Human menstrual blood | Multiple cytokines | (27) |
D-Gal-N/LPS in mice | TNFα-treated human umbilical cord | miR-299-3p | (242) |
D-Gal-N/LPS in mice | Adipose tissue | H19 | (86) |
D-Gal-N/LPS in mice | Adipose tissue | miR-17 | (135) |
Ischemia reperfusion injury (IRI) in mice | Human bone marrow | (4) | |
IRI in mice | Mouse bone marrow | (61) | |
ConA in mice | Mouse bone marrow | (204) | |
CCl4 in mice | Human placenta | (21) | |
2/3 partial hepatectomy + IRI in rats | Rat bone marrow | (33) | |
CCl4 in rats | Rat bone marrow | (33) | |
Chronic CCl4 in mice | Human umbilical cord blood | (124) | |
Mdr2−/− mice | Human bone marrow | (5) | |
Liver antigens S100 | Mouse bone marrow | miR-223 | (26) |